Mirimus' mission is to change the paradigm of the current drug discovery process by developing superior preclinical RNA interference (RNAi) animal models that can predict toxicities of potential drug therapies without the actual drug itself.

Biotechnology

Mirimus

Mirimus' headquarters in NY, United States

Prem Premsrirut

James Connolly

Giuseppe Militello

Sean Seibel

Veronica Andrews

David Eads

Subree Subramanian

Linda E Amper

Rachelle P. Mendoza

Gary Yen

Edward V Quadros

Aiqun Li

Elisa Riedo

Johannes Zuber

Lukas Dow

Christopher E. Mason

Stephen Chang

Stephen Elledge

Greg Hannon

The Advisory Team at Mirimus provides expert guidance and strategic insights to enhance the development and application of preclinical RNA interference (RNAi) animal models, ensuring they accurately predict drug toxicities and optimize the drug discovery process. This team leverages diverse expertise in scientific research and strategic planning to support and refine Mirimus' innovative mission.

Advisory Team

The Leadership Team at Mirimus is responsible for guiding the strategic direction of the company, overseeing research and development initiatives, and ensuring operational efficiency to achieve the mission of enhancing drug discovery through innovative RNAi animal models. This team combines expertise from various fields, including translational research, finance, technology, and human resources, to drive growth and foster a collaborative company culture.

Leadership Team

The Scientific Research team at Mirimus focuses on advancing the field of drug discovery by developing and utilizing sophisticated RNA interference (RNAi) animal models. They specialize in predicting the toxicities of potential drug therapies, thereby eliminating the need for actual drug testing during the preclinical phase. Their diverse expertise spans biotechnology, cell biology, neuroscience, immunology, cancer biology, genetics, and genetic engineering to ensure comprehensive and innovative research outcomes.

Scientific Research

The Executives at Mirimus lead strategic initiatives, driving the company's mission forward. The Chief Sales Officer oversees sales strategies and client relationships, the Chief People Officer focuses on talent management and organizational culture, the Chief Financial Officer manages financial planning and stability, and the Chief Product & Technology Officer directs product development and technological innovation. Together, they ensure the successful execution of Mirimus' pioneering approach in preclinical RNAi animal models for drug discovery.

Executives

This department focuses on advancing scientific knowledge and developing innovative solutions through research initiatives.

Mirimus

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Scientific Research

Executives

Research and Development

Offices

Mirimus

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Scientific Research

Executives

Research and Development

Offices

Related companies